Regulatory/Compliance Filing
Chennai Meenakshi Multispeciality Hospital Issues Duplicate Certificate
Chennai Meenakshi Multispeciality Hospital issued a duplicate share certificate for 100 shares held by Inder Chand Kothari L under Regulation 39(3).
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
3
Neutral
7
Bullish
4
Bearish
31
Neutral
7
Bullish
8
Bearish
28
Neutral
0
Bullish
4
Bearish
28
Neutral
0
Bullish
4
Bearish
28
Neutral
0
Bullish
4
Bearish
28
Neutral
0
Bullish
4
Healthcare Services
Healthcare Service Provider
27 Cr
Low Risk
-31.5
59.7
—
—
51.86
31.51
Sales CAGR
Profit CAGR
ROE
ROCE

Chennai Meenakshi Multispeciality Hospital Ltd (CMMHOSP) is currently trading at 36.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Chennai Meenakshi Multispeciality Hospital Limited is a healthcare provider located in Mylapore, Chennai. It offers a range of services including cardiology, nephrology, physiotherapy, and intensive care. The hospital is well-equipped with advanced medical technology, offering services like CT scans, X-rays, ultrasounds, and echocardiograms. It operates a 24-hour Casualty Department providing emergency and trauma care with skilled medical officers and paramedical teams. The institution boasts a 12-bedded IMCU/ICCU managed by trained staff and duty doctors, equipped with modern monitors, ventilators, defibrillators, and CPAP machines. Chennai Meenakshi Multispeciality Hospital emphasizes quality healthcare services supported by a team of talented and experienced doctors and dedicated support staff.
Over the past 52 weeks, Chennai Meenakshi Multispeciality Hospital Ltd has traded between a low of ₹31.51 and a high of ₹51.86. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Chennai Meenakshi Multispeciality Hospital Ltd has a market capitalization of approximately 26.74. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Chennai Meenakshi Multispeciality Hospital Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -31.46 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 26.74 Cr, Chennai Meenakshi Multispeciality Hospital Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Chennai Meenakshi Multispeciality Hospital Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Chennai Meenakshi Multispeciality Hospital Ltd is -31.46. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Regulatory/Compliance Filing
Chennai Meenakshi Multispeciality Hospital issued a duplicate share certificate for 100 shares held by Inder Chand Kothari L under Regulation 39(3).
Legal/Regulatory Proceedings
Chennai Meenakshi Multispeciality Hospital disclosed a procedural court order impleading co-owners in a pending eviction petition concerning leased hospital premises, with no immediate quantifiable financial impact.